Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DROP: Valsartan for Proteinuria in Hypertensive Type 2 Diabetics
NCT00241085Phase 4Completed
- Sponsor
- Novartis
- Start
- Nov 2002
- Primary completion
- Aug 2005
- Modality
- Small Molecules
01
Overview
Phase 4, randomised, double-blind trial of valsartan in proteinuria (3 arms), sponsored by Novartis. Primary endpoint: Change from baseline in urinary protein excretion at 30 weeks. Started Nov 2002; status: completed.
02
Drugs
valsartan
03
Conditions
proteinuria
Beyond the preview
Go deeper on NCT00241085.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00241085.